Back to the main directory
Company Analysis / Equity
- Revenue Prioritized Over Margins in Ericsson's 2Q, Pressure to Continue; Maintaining SEK 81 FVE by Morningstar
- Contraction of Camera Market Will Be Compensated by Other Businesses, Cut Canon's FVE to JPY 3,600 by Morningstar
- Morningstar | RDSB Updated Forecasts and Estimates from 07 May 2019 by Morningstar
- Memory Recovery is Mostly Embedded to the Share Price; Retain Samsung’s FVE of KRW 51,000 by Morningstar
- Nidec’s Margins to Recover on Restructure and Auto Related Motor Demand, FVE Unchanged by Morningstar
- Lear Cuts 2019 Guidance; Maintaining $122 Fair Value Estimate by Morningstar
- Morningstar | Caesars Shareholders Win With Eldorado's $12.75 Per Share Bid, Leaving Shares Fairly Valued by Morningstar
- We Think Xylem's Smart Water Strategy Will Help Widen Its Moat by Morningstar
- Further Restrictions to Data Tracking May Hit Criteo Once Again; Lowering FVE to $25 by Morningstar
- Morningstar | Putting American Airlines Coverage Under Review by Morningstar
- Morningstar | Initiating on Fast-Growing Cannabis Industry: We See Aurora Cannabis as Undervalued. See Updated Analyst Note from 27 Jun 2019 by Morningstar
- We Expect Zayo’s Deal to Be Acquired for $35 per Share in Cash Will Go Through in 2020’s First Half by Morningstar
- Morningstar | Park Hotels Announces Acquisition of Chesapeake Lodging Trust, Reports Strong 1Q Results by Morningstar
- Morningstar | ASML Overcomes Industry Weakness With Solid Second-Quarter Results; Shares Remain Overvalued by Morningstar
- Morningstar | Consistency Rules as Accenture Reports Good 3Q, Leads in Digital; Shares at Premium by Morningstar
- Morningstar | Santander's 1Q Run Rate Below Our Expectations for Full Year by Morningstar
- Morningstar | DCB and Currency Drag Down Becton, Dickinson's Second-Quarter Performance and Full-Year Guidance by Morningstar
- Morningstar | Acquisitions and Booming Biotech Environment Drive Charles River's Growth; Shares Look Overvalued. See Updated Analyst Note from 07 May 2019 by Morningstar
- Morningstar | Fiscal 2019 Will Be Year of Transition for Commercial Metals, but 1H Results Encouraging by Morningstar
- Strong Start for Fresenius Medical Care Bodes Well for Dialysis Providers by Morningstar
- As Family Dollar Rebounds, Dollar Tree Should Deliver Improving Results; Shares Somewhat Rich by Morningstar
- Morningstar | Fiserv Holds Steady in 1Q by Morningstar
- Morningstar | After Taking a Fresh Look at Fluor, We Lower FVE to $46 and Moat Rating to None. See Updated Analyst Note from 29 Apr 2019 by Morningstar
- Morningstar | An in Line Quarter for Host Hotels Despite Negative Revenue Per Available Room Growth by Morningstar
- Morningstar | No-Moat Hain Focused on U.S. Turnaround in Highly Competitive Health and Wellness Space by Morningstar